Akela Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1996-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://akelapharma.com
Clinical Trials
10
Active:5
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 3:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 3
5 (83.3%)Phase 1
1 (16.7%)Safety of Fentanyl TAIFUN Treatment
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2009-01-14
- Lead Sponsor
- Akela Pharma, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT00822614
- Locations
- 🇵🇱
NZOZ, Wloclawek, Wolnosc, Poland
News
No news found